Latest News about ACAD
Recent news which mentions ACAD
From InvestorPlace
Acadia Pharmaceuticals Gets Price Target Bumps By Analysts After FDA Approval Of Rett Syndrome Drug
March 14, 2023
Tickers
ACAD
From Benzinga
From Benzinga
Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket
March 13, 2023
From Benzinga
3 Nasdaq Stocks on Watch This Week
March 12, 2023
From Motley Fool
1 Top Biotech Stock to Buy in March
March 07, 2023
From Motley Fool
Analysts See Steady Growth For Acadia Pharma's Nuplazid
February 28, 2023
Tickers
ACAD
From Benzinga
What 10 Analyst Ratings Have To Say About ACADIA Pharmaceuticals
February 28, 2023
Tickers
ACAD
From Benzinga
Earnings Scheduled For February 27, 2023
February 27, 2023
From Benzinga
Analyst Expectations for ACADIA Pharmaceuticals's Future
January 31, 2023
Tickers
ACAD
From Benzinga
Mizuho Maintains Neutral Rating for ACADIA Pharmaceuticals: Here's What You Need To Know
December 21, 2022
Tickers
ACAD
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
November 04, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
From Benzinga
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
From Benzinga
U.S. FDA Accepts Acadia's Filing For Rett Syndrome Candidate Under Priority Review
September 12, 2022
Tickers
ACAD
From Benzinga
From Benzinga
ACADIA Pharmaceuticals's Return On Capital Employed Insights
August 29, 2022
Tickers
ACAD
From Benzinga
From Benzinga
ACADIA Pharmaceuticals Faces Several Price Target Cuts After Q2 Results, But This Analyst Disagrees
August 09, 2022
Tickers
ACAD
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.